Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line
NIHR HSC
Record ID 32015000137
English
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.hsc.nihr.ac.uk/topics/asunaprevir-beclabuvir-and-daclatasvir-fixed-dose/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- RNA, Viral
- Antiviral Agents
- Hepacivirus
- Dose-Response Relationship, Drug
- Viral Nonstructural Proteins
- Drug Therapy, Combination
- Recombinant Proteins
- Genotype
- Liver Cirrhosis
- Protease Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Hepatitis C, Chronic
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Centre (NIHR HSC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.